MUST Researchers Develop Herbal Supplement to Support Immunity Among People Living with HIV
Home Trending News Current Affairs MUST Researchers Develop Herbal Supplement to Support Immunity Among People Living with HIV

MUST Researchers Develop Herbal Supplement to Support Immunity Among People Living with HIV

Researchers at Mbarara University of Science and Technology (MUST) are developing a herbal supplement intended to support immunity among people living with HIV when used alongside antiretroviral therapy (ART).

The product, initially developed from a combination of two medicinal plants and named Moatem Capsules, is expected to be rebranded as Novimunol as the research team prepares to submit it to the National Drug Authority (NDA) for regulatory assessment.

Dr Jimmy Ronald Angupale, Head of Product Development at MUST’s Pharm-Biotechnology and Traditional Medicine Centre (PHARMBIOTRAC), said the innovation builds on doctoral research conducted in 2017 that examined the potential benefits of combining medicinal plants with antiretroviral medicines.

Speaking at the university’s fifth HIV and AIDS Symposium, Angupale said research findings suggest the herbal combination could improve immunity without interfering with the effectiveness of ART when taken as a supplement.

He said the product is being developed to address some of the challenges faced by people living with HIV, including weakened immunity and complications associated with long-term treatment. However, further work is needed to standardise the formulation by identifying and measuring its active compounds.

The process will help researchers establish appropriate dosages and assess the product’s safety and quality. The team is also refining the formulation into capsules and tablets to improve stability and make it easier to administer than liquid preparations.

Angupale called for increased and sustained government funding for scientific research, particularly in universities, saying inadequate financing continues to limit the development and commercialisation of locally developed innovations.

Meanwhile, Dr Flavia Matovu Kiweewa, Head of Research at the Makerere University-Johns Hopkins University Research Collaboration, urged the government to invest more in HIV research, including studies on the use of Lenacapavir among children.

She said research should explore more effective and convenient HIV prevention and treatment options for children, particularly alternatives that reduce the burden of daily medication and the challenges associated with administering syrup formulations.

The proposed supplement is still undergoing development and has not yet received regulatory approval. Researchers are expected to submit it to the NDA for assessment before it can be considered for wider use.

Check Also

Masaka Lawyers Challenge Judiciary’s Decision to Hold Murder Trial at Ssaza Grounds

The Uganda Law Society (ULS) Masaka Chapter has challenged the Judiciary’s decision to con…